Early Cancer Detection in General Practice: A Major New NHS Development

A Major Week for Cancer Diagnosis and General Practice

Early cancer detection in general practice is becoming an increasingly important focus for the NHS as new technology, rising cancer diagnoses and changing approaches to referral continue to influence primary care. This week has brought significant attention to cancer diagnosis after new figures showed that more than 1,000 people a day were diagnosed with cancer in England during 2024.

At the same time, the NHS has launched a major trial involving new blood tests that could eventually help GPs identify several types of cancer earlier. The trial is being delivered across more than 200 GP practices in England and will involve more than 20,000 patients experiencing symptoms such as abdominal discomfort and bloating.

For general practice, this development is particularly significant.

GPs are often the first healthcare professionals to assess patients with symptoms that could have many different causes. Deciding which patients require further investigation or an urgent referral is an important part of primary care.

The potential introduction of new diagnostic tools could therefore change how some of these decisions are made.

Cancer Diagnoses Have Reached a Record High

New figures reported this week show that England recorded more than 373,000 new cancer diagnoses during 2024. This represents an average of approximately 1,021 diagnoses every day and is the highest annual total recorded.

The increase is not necessarily an indication that cancer itself is becoming dramatically more common in every part of the population. An ageing population, improved testing and increased detection all contribute to the growing number of diagnoses.

However, the figures highlight the continuing importance of early diagnosis.

The earlier a cancer is identified, the more opportunities there may be for treatment. This makes the role of general practice particularly important because patients often present to their GP before they have a confirmed diagnosis.

For practice teams, this means maintaining awareness of symptoms, using appropriate referral pathways and ensuring patients receive timely follow-up.

Cancer diagnosis can also create significant administrative workload. Referrals need to be processed, results reviewed and patients contacted. Practices may also need to coordinate information between hospitals, diagnostic services and patients.

As cancer diagnoses increase, the workload associated with diagnosis and follow-up will remain an important consideration for primary care.

A New Blood Test Trial Could Change the Diagnostic Pathway

One of the most significant developments this week is the launch of a major NHS trial investigating new blood tests for cancer detection.

The STRIDE-RCT trial is being led by the University of Birmingham and will involve more than 20,000 patients experiencing abdominal symptoms across more than 200 GP practices in England. Researchers will assess whether three blood tests can help identify 13 different types of cancer at an earlier stage.

The cancers being investigated include bowel, stomach, pancreatic, liver, ovarian, kidney and prostate cancers.

The tests look for biological indicators associated with cancer, including fragments of tumour DNA and proteins linked to the body’s immune response.

Importantly, these tests are being assessed as tools to support clinical decision-making. A positive result would not mean that a patient definitely has cancer.

Instead, the information could potentially help GPs decide which patients may benefit from urgent further investigation.

This distinction is extremely important.

The purpose of the trial is not to replace clinical judgement. It is to investigate whether additional information can help clinicians make better-informed decisions about referrals.

What Could This Mean for GPs?

If the technology proves effective, it could eventually become another tool available to general practice.

GPs regularly assess symptoms that could indicate many different conditions. Abdominal discomfort, bloating, unexplained weight loss and changes in bowel habits, for example, can have numerous causes.

The challenge is identifying the patients who require urgent investigation while avoiding unnecessary referrals for patients who are unlikely to have serious disease.

A reliable additional test could potentially support this decision-making process.

It could help provide greater confidence when deciding whether a patient requires an urgent referral. It could also potentially reduce some unnecessary referrals if testing helps clinicians identify patients who do not require immediate specialist investigation.

However, the evidence needs to come first.

The trial is designed to determine whether these tests actually improve outcomes and referral decisions in real-world primary care.

That is an important safeguard. New technology may appear promising, but primary care needs evidence that a diagnostic tool is accurate, clinically useful and practical before widespread adoption.

Early Diagnosis Could Also Affect Patient Experience

Cancer investigations can be stressful for patients.

Being referred urgently can create significant anxiety, particularly when patients do not know what will happen next. At the same time, delays can create uncertainty and may postpone diagnosis.

Better diagnostic information could potentially improve this process.

If GPs have greater confidence when assessing symptoms, patients may receive more appropriate referrals and clearer explanations about the next steps.

However, communication will remain essential.

Even if a new blood test produces a reassuring result, patients with persistent or concerning symptoms may still require further assessment. Similarly, a positive result would require appropriate follow-up rather than being treated as a diagnosis in itself.

Technology can provide information, but communication and clinical judgement remain central.

The Pressure on Cancer Referral Pathways

The increasing number of cancer diagnoses also raises questions about capacity within secondary care.

If more patients receive urgent referrals, diagnostic services need enough capacity to investigate them.

General practice cannot improve early diagnosis in isolation.

The wider pathway needs to function effectively.

Patients may move from their GP to a diagnostic service and then to a specialist team. Each stage requires capacity, communication and timely information sharing.

If diagnostic technology increases the number of patients identified as potentially requiring investigation, the NHS must ensure that downstream services can respond.

Otherwise, improved detection could simply create new pressure elsewhere.

This is why the trial is so important. It needs to assess not only whether the tests identify cancer but also how they affect the wider healthcare system.

Prevention and Early Detection Remain Central to Primary Care

The developments this week also reinforce the wider role of primary care in prevention.

Cancer prevention involves more than diagnosis. Lifestyle factors, screening participation and awareness of symptoms all play important roles.

General practice has a significant role in encouraging patients to attend screening programmes and supporting people who may have risk factors.

The NHS is also continuing to focus on improving cancer diagnosis at earlier stages. New figures show that the proportion of cancers diagnosed at stages one or two increased from 55.8% in 2023 to 56.7% in 2024.

Although this represents progress, the latest figures also show that significant challenges remain.

In August 2026, 78.6% of urgently referred patients received a diagnosis or had cancer ruled out within 28 days. The target is 80%. Only 71.9% of patients began treatment within 62 days, compared with the 85% target.

These figures demonstrate why early diagnosis needs to be considered across the entire healthcare pathway.

What This Means for Practice Managers

For practice managers, developments in cancer diagnosis may initially appear to be primarily clinical issues. However, they can have significant operational implications.

New diagnostic tools may create additional requests for appointments, blood tests, results management and follow-up. Practices may also need to introduce new workflows if testing becomes more widely available.

Administrative teams will play an important role in ensuring that referrals, results and patient communications move through the practice efficiently.

Clinical teams will also need clear guidance about how new tests should be used and how results should influence patient management.

This highlights a wider principle in primary care transformation: introducing new technology is only part of the process.

The practice also needs the systems, training and workforce capacity to use it effectively.

Technology Should Support Clinical Judgement

The potential use of blood tests for earlier cancer detection demonstrates how technology could support general practice.

However, it is important that technology remains a tool rather than a replacement for clinical judgement.

GPs consider a patient’s symptoms, history, examination findings and wider circumstances when making decisions. A test result provides another piece of information, but it cannot necessarily capture the full clinical picture.

The NHS will therefore need to ensure that any future diagnostic technology has clear guidance around its use.

Practices will also need confidence that new systems are safe, evidence-based and practical.

The National Commission into the Regulation of AI in Healthcare has already emphasised the importance of safety, transparency, accountability and ongoing monitoring as healthcare technology develops.

Although the new cancer blood tests are not simply an AI intervention, the same broader principle applies: innovation must be introduced alongside appropriate safeguards.

The Management Message: Earlier Detection Needs the Whole System

This week’s developments provide an important reminder of the central role general practice plays in cancer diagnosis.

More than 1,000 people are now diagnosed with cancer in England every day, while new NHS research is exploring whether blood tests could help GPs identify certain cancers earlier.

The potential benefits are significant.

Earlier diagnosis could improve treatment options and patient outcomes. Better information could also help GPs make more informed referral decisions.

However, successful implementation will depend on more than the test itself.

Practices will need appropriate training, clear processes and sufficient capacity. Diagnostic services and hospitals will also need the resources to respond to referrals generated through improved detection.

For practice managers and primary care leaders, the message is clear: innovation must be accompanied by operational planning.

Early cancer detection in general practice could become an important part of the future of NHS care. The current trial will help determine whether these new blood tests can deliver meaningful benefits for patients and clinicians.

For now, the priority remains evidence, safe implementation and effective coordination.

General practice sits at the beginning of many patient journeys through the NHS. Strengthening the tools available to GPs could make an important difference, but only if the wider system is ready to support the changes that follow.

As the NHS continues to focus on earlier diagnosis, prevention and improving outcomes, general practice will remain central to turning these ambitions into practical improvements for patients.

Tuesday Talks: Your Weekly Insight into Primary Care

Stay up to date with the latest developments in primary care with Tuesday Talks — our weekly series for healthcare professionals. Each episode highlights current industry news, NHS policy changes, and what these mean for general practice.

We also showcase how General Practice Solutions (GPS) is supporting practices with innovative services designed to meet today’s challenges. Whether you need expert commentary or practical guidance, Tuesday Talks provides timely, relevant content to keep you informed and prepared.

Watch the latest episode below and stay ahead in a fast-changing healthcare landscape.

Workforce Wednesdays: Practical HR Insights for Primary Care

Workforce challenges continue to shape the daily reality of primary care, and therefore Workforce Wednesdays provides a weekly series that explores the HR issues that matter most to NHS practices — from absence management and contractual changes through to employment law updates and staff wellbeing.

In each episode, you will not only find clear, practical guidance

but also step-by-step support to help practice leaders manage staffing pressures with confidence. The content addresses both immediate concerns, such as day-to-day rota gaps, and longer-term workforce strategies, while also offering insights tailored specifically to the primary care setting.

Welcome to Thoughtful Thursday, our weekly series celebrating the uplifting and inspiring moments from across primary care. In addition, each episode highlights stories of innovation, kindness, and community spirit that together showcase the very best of general practice.

This week, you will discover a moving story of compassion and real-world impact; moreover, it serves as a reminder of the dedication and resilience at the heart of our sector.

Ultimately, Thoughtful Thursday is a must-watch for anyone who believes in the power of care.